Clinical trials
Non-segmental Vitiligo clinical trials
Below are recruiting non-segmental vitiligo clinical trials, each written for real people, not researchers. We’re tracking 17 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07431177RecruitingPhase 2
Study of an investigational drug for non-segmental vitiligo
This study tests an investigational drug (GIA632) in people with non-segmental vitiligo. It aims to see if different doses can safely and effectively restore color to white patches.
Birmingham, AlabamaAges 18–99 - NCT07682506RecruitingPhase 3
Testing a new vitiligo ointment for face and body patches
This trial tests an ointment called MH004 to see if it helps repigment white patches in people with non-segmental vitiligo (the most common type). It focuses on patches on the face and body.
Beijing, Beijing MunicipalityAges 12–75 - NCT06511739RecruitingPhase 2
SYHX1901 tablet for non-segmental vitiligo
This study tests an oral tablet called SYHX1901 for people with non-segmental vitiligo. It aims to see if the pill is safe and effective at bringing back skin color.
ShijiazhuangAges 18–65 - NCT07105254RecruitingPhase 2
Roflumilast foam study for children with vitiligo
This study tests a medicated foam (Roflumilast) in children with non-segmental vitiligo to see if it can improve skin color on the face and body. It is for patients aged 2 to 17 with small patches and at least some pigmented hair in the face patches.
Dallas, TexasAges 2–18 - NCT07712523RecruitingPhase 2
Testing QY201 tablets for non-segmental vitiligo
This trial tests an experimental oral tablet called QY201 to see if it can improve vitiligo (white patches on the skin). It is for adults with non-segmental vitiligo, regardless of whether the patches are currently growing or stable.
Shenyang, LiaoningAges 18–65 - NCT07251595RecruitingPhase 2
Testing a pill and gel for vitiligo
This trial tests two forms of a drug (SHR0302) for non-segmental vitiligo. One is a pill, the other a gel. The goal is to see if they can repigment the skin with fewer side effects.
Jinan, ShandongAges 18–75 - NCT07172347RecruitingPhase 2
VC005 tablets for non-segmental vitiligo
This trial tests an oral tablet called VC005 to see if it can help treat non-segmental vitiligo. It may be an option for adults with vitiligo patches that are not limited to one area of the body.
Beijing, BeijngAges 18–75 - NCT07223229RecruitingPhase 2
Testing EI-001 for vitiligo that hasn't improved with other treatments
This study tests a new drug called EI-001 for people with non-segmental vitiligo (a type where white patches appear on both sides of the body). It is for those whose vitiligo has not gotten better with standard treatments like creams or light therapy, or who cannot use those treatments.
Huntington Beach, CaliforniaAges 18–65 - NCT07047612RecruitingPhase 2/Phase 3
A study of ICP-332 for people with non-segmental vitiligo
This trial tests an investigational drug called ICP-332 for vitiligo that isn't limited to one area (non-segmental). It aims to see if the drug can help restore skin color. The study is for both adults and teenagers who have had vitiligo for at least 3 months with a certain amount of skin affected.
Wuhu, AnhuiAges 12–75 - NCT07625891RecruitingPhase 2
Testing D-2570 for non-segmental vitiligo
This Phase 2 trial tests whether a new drug called D-2570 can help restore skin color in people with non-segmental vitiligo (when white patches appear randomly across the body). The study will track how well the drug works and check if it's safe to use.
Shanghai, Shanghai MunicipalityAges 18–65 - NCT06905873RecruitingPhase 1
Testing FB102 for non-segmental vitiligo
This study tests a new medicine called FB102 for people with non-segmental vitiligo. It aims to see if the drug is safe and helps restore skin color.
Darlinghurst, New South WalesAges 18–75 - NCT06991972RecruitingPhase 4
Needling vs. microneedling plus light therapy for vitiligo
This trial compares two types of needle treatments (needling and microneedling) combined with light therapy to see which works better for people with vitiligo that has lasted more than a year.
Peshawar, Khyber PakhtunkhwaAges 15–60 - NCT07136467Recruiting
Understanding daily life with vitiligo, alopecia areata, or hidradenitis suppurativa
This study looks at how certain skin conditions affect daily life in teens and adults. Researchers want to understand the challenges people face with vitiligo, alopecia areata, or hidradenitis suppurativa by having participants fill out simple questionnaires.
Ciudad Autonoma de Buenos Aire, Buenos AiresAges 12 years+ - NCT07357870RecruitingPhase 1
Cream study for facial vitiligo
This trial tests a new cream for vitiligo on the face or neck. It aims to see if the cream can help bring color back to white patches.
Ankara, TurkeyAges 18–60 - NCT07533019RecruitingPhase 2
Testing LY4005130 for non-segmental vitiligo
This study tests a new medicine called LY4005130 for non-segmental vitiligo, a skin condition where patches lose pigment (color). The trial aims to see if this drug can help restore skin color and stop the spread of white patches.
Phoenix, ArizonaAges 18–75 - NCT07554222RecruitingPhase 1
Safety study of IBI3013 for vitiligo and hair loss
This is an early-stage safety study of a new drug called IBI3013. The trial tests how safe the drug is and how your body processes it. It enrolls healthy volunteers first, then people with vitiligo (loss of skin color) or severe alopecia areata (patchy hair loss).
Shanghai, Shanghai MunicipalityAges 18–80 - NCT07187882Recruiting
Skin cell transplant for vitiligo treatment
This trial tests a surgery that uses your own skin cells to treat stable vitiligo patches. It may help when creams or light therapy haven't worked.
Beijing, Beijing MunicipalityAges 8–65
Hear when a new Non-segmental Vitiligo trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Non-segmental Vitiligo trials by city
Studies with a site in or near these metro areas.
Non-segmental Vitiligo trials by state
Studies with a site anywhere in these states.
Common questions
- Are there clinical trials for non-segmental vitiligo?
- Yes. Clin2 currently lists 17 recruiting non-segmental vitiligo studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a non-segmental vitiligo trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a non-segmental vitiligo trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.